Fast-track status is intended to speed the development and review of treatments for serious conditions with unmet medical needs. It will allow Spinogenix to have more frequent interactions with the ...

Acurastem has received $7.5 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance AS-241, its lead clinical candidate for amyotrophic lateral sclerosis (ALS) and ...

The drug is for a small subset of patients. But evidence that breathing and strength can get better for some of them is ...

The FDA has granted Fast Track designation to tazbentetol for the treatment of amyotrophic lateral sclerosis (ALS).

The agency said NfL could be used as a marker to predict patient benefit, but more data is still needed to confirm that link.

According to the CDC, around 5,000 people in the U.S. are diagnosed with ALS every year. There is no cure for this neurological illness. Although anglers across the Northland were taking advantage of ...

The search for an ALS cure, which has remained a mystery to the health care community, is now being sought out with the help of artificial intelligence. AI is being used to better coordinate all the ...